Literature DB >> 15114010

Growing poxviruses and determining virus titer.

Girish J Kotwal1, Melissa-Rose Abrahams.   

Abstract

Poxviruses are cell-associated viruses that can be grown in adherent- or suspension-cell cultures or chorioallantoic membranes of embryonated hen's eggs. The main principle of isolating the virus is to mechanically lyse infected cells. The virus can then be semipurified by centrifugation through a sucrose cushion. Further purification can be achieved with a sucrose gradient. This chapter describes methods for the preparation of large-scale growth and purification of the virus.

Entities:  

Mesh:

Year:  2004        PMID: 15114010     DOI: 10.1385/1-59259-789-0:101

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  16 in total

1.  N1L is an ectromelia virus virulence factor and essential for in vivo spread upon respiratory infection.

Authors:  Meike S Gratz; Yasemin Suezer; Melanie Kremer; Asisa Volz; Monir Majzoub; Kay-Martin Hanschmann; Ulrich Kalinke; Astrid Schwantes; Gerd Sutter
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

2.  Myxoma virus: propagation, purification, quantification, and storage.

Authors:  Sherin E Smallwood; Masmudur M Rahman; Dorothy W Smith; Grant McFadden
Journal:  Curr Protoc Microbiol       Date:  2010-05

3.  Type I interferon mimetics bypass vaccinia virus decoy receptor virulence factor for protection of mice against lethal infection.

Authors:  Chulbul M Ahmed; Howard M Johnson
Journal:  Clin Vaccine Immunol       Date:  2014-06-25

4.  Influence of glycosylation and oligomerization of vaccinia virus complement control protein on level and pattern of functional activity and immunogenicity.

Authors:  Girish J Kotwal
Journal:  Protein Cell       Date:  2011-01-08       Impact factor: 14.870

5.  The heterogeneity of human antibody responses to vaccinia virus revealed through use of focused protein arrays.

Authors:  Jonathan S Duke-Cohan; Kristin Wollenick; Elizabeth A Witten; Michael S Seaman; Lindsey R Baden; Raphael Dolin; Ellis L Reinherz
Journal:  Vaccine       Date:  2009-01-13       Impact factor: 3.641

6.  Poxviruses as Gene Therapy Vectors: Generating Poxviral Vectors Expressing Therapeutic Transgenes.

Authors:  Steven J Conrad; Jia Liu
Journal:  Methods Mol Biol       Date:  2019

7.  MAVERICC: Marker-free Vaccinia Virus Engineering of Recombinants through in vitro CRISPR/Cas9 Cleavage.

Authors:  Ethan Laudermilch; Kartik Chandran
Journal:  J Mol Biol       Date:  2021-02-24       Impact factor: 5.469

8.  Rapid and sensitive point-of-care detection of Orthopoxviruses by ABICAP immunofiltration.

Authors:  Daniel Stern; Victoria A Olson; Scott K Smith; Marko Pietraszczyk; Lilija Miller; Peter Miethe; Brigitte G Dorner; Andreas Nitsche
Journal:  Virol J       Date:  2016-12-09       Impact factor: 4.099

9.  Phylogenetic and histological variation in avipoxviruses isolated in South Africa.

Authors:  Kristy Offerman; Olivia Carulei; Tertius A Gous; Nicola Douglass; Anna-Lise Williamson
Journal:  J Gen Virol       Date:  2013-07-16       Impact factor: 3.891

10.  Safety and biodistribution of a double-deleted oncolytic vaccinia virus encoding CD40 ligand in laboratory Beagles.

Authors:  Karoliina Autio; Anna Knuuttila; Anja Kipar; Sari Pesonen; Kilian Guse; Suvi Parviainen; Minna Rajamäki; Outi Laitinen-Vapaavuori; Markus Vähä-Koskela; Anna Kanerva; Akseli Hemminki
Journal:  Mol Ther Oncolytics       Date:  2014-12-10       Impact factor: 7.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.